109229-58-5Relevant articles and documents
ABC EXPRESSION PROMOTERS
-
, (2008/06/13)
The ABCA1 mRNA expression-promoting agent, LXRα mRNA expression-promoting agent, ABCG1 mRNA expression-promoting agent, cholesterol efflux-promoting agent, cholesteryl ester accumulation-inhibiting agent, ACAT-1 mRNA expression-inhibiting agent and CEH mRNA expression-promoting agent of the present invention are excellent in the ability to control cholesterol distribution in the body and have low toxicity.
Agent for improving ketosis
-
, (2008/06/13)
An agent for improving ketosis which comprises an insulin sensitizer, which has an excellent action and low toxicity.
Method for preventing and for treating autoimmune disease
-
, (2008/06/13)
A method for preventing or treating autoimmune diseases (excluding type I diabetes) by administering an insulin resistance improving substance as an active ingredient.
Use of thiazolidinedione derivatives in the treatment of insulin resistance
-
, (2008/06/13)
The present invention provides methods of using thiazolidinedione in the treatment of insulin resistance.
Substituted Dihydrobenzopyran and Dihydrobenzofuran Thiazolidine-2,4-diones as Hypoglycemic Agents
Clark, David A.,Goldstein, Steven W.,Volkmann, Robert A.,Eggler, James F.,Holland, Gerald F.,et al.
, p. 319 - 325 (2007/10/02)
A series of dihydrobenzofuran and dihydrobenzopyran thiazolidine-2,4-diones (compounds 3-26) was synthesized from the corresponding aryl aldehydes 1 in two steps.These compounds represent conformationally restricted analogues of the novel hypoglycemic cig